1. Home
  2. CPIX vs SCNX Comparison

CPIX vs SCNX Comparison

Compare CPIX & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • SCNX
  • Stock Information
  • Founded
  • CPIX 1999
  • SCNX 2010
  • Country
  • CPIX United States
  • SCNX United States
  • Employees
  • CPIX N/A
  • SCNX N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • SCNX Other Pharmaceuticals
  • Sector
  • CPIX Health Care
  • SCNX Health Care
  • Exchange
  • CPIX Nasdaq
  • SCNX Nasdaq
  • Market Cap
  • CPIX 35.4M
  • SCNX 33.6M
  • IPO Year
  • CPIX 2009
  • SCNX 2020
  • Fundamental
  • Price
  • CPIX $4.64
  • SCNX $3.45
  • Analyst Decision
  • CPIX
  • SCNX
  • Analyst Count
  • CPIX 0
  • SCNX 0
  • Target Price
  • CPIX N/A
  • SCNX N/A
  • AVG Volume (30 Days)
  • CPIX 4.5M
  • SCNX 10.8K
  • Earning Date
  • CPIX 03-04-2025
  • SCNX 02-18-2025
  • Dividend Yield
  • CPIX N/A
  • SCNX N/A
  • EPS Growth
  • CPIX N/A
  • SCNX N/A
  • EPS
  • CPIX N/A
  • SCNX 3.55
  • Revenue
  • CPIX $36,785,442.00
  • SCNX N/A
  • Revenue This Year
  • CPIX N/A
  • SCNX $1,085.75
  • Revenue Next Year
  • CPIX N/A
  • SCNX N/A
  • P/E Ratio
  • CPIX N/A
  • SCNX $1.50
  • Revenue Growth
  • CPIX N/A
  • SCNX 166.67
  • 52 Week Low
  • CPIX $1.04
  • SCNX $3.07
  • 52 Week High
  • CPIX $6.43
  • SCNX $44.56
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 83.81
  • SCNX N/A
  • Support Level
  • CPIX $2.08
  • SCNX N/A
  • Resistance Level
  • CPIX $6.43
  • SCNX N/A
  • Average True Range (ATR)
  • CPIX 0.53
  • SCNX 0.00
  • MACD
  • CPIX 0.27
  • SCNX 0.00
  • Stochastic Oscillator
  • CPIX 74.94
  • SCNX 0.00

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About SCNX Scienture Holdings Inc. Common Stock

Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.

Share on Social Networks: